Why Healthpeak Properties Is On Investors’ Radar

Healthpeak Properties (DOC) is drawing interest after recent trading left the stock with a 1 day gain of 0.49% but negative returns over the week, month, and past 3 months.

That 0.49% 1 day share price gain to US$16.41 comes after weaker recent momentum, with a 90 day share price return of a 9.24% decline and a 1 year total shareholder return of a 6.43% loss, suggesting sentiment has been fading rather than building.

If you are looking beyond a single healthcare REIT, this could be a useful moment to broaden your watchlist and uncover 17 top founder-led companies

With the share price under pressure over 1, 3, and 5 years, yet trading at what some analysts see as a discount to their price targets and certain intrinsic estimates, is there a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 18.6% Undervalued

At a last close of $16.41, the most followed narrative for Healthpeak Properties points to a fair value of about $20.17, implying meaningful upside in that model.

Supply constraints in key outpatient and life sciences markets (notably lower new construction over the past two decades and removal of uncompetitive inventory) are tightening available space, positioning Healthpeak's concentrated, high-quality portfolio to benefit from robust re-leasing spreads, supporting stronger net operating income and rent growth.

Curious what is baked into that $20.17 fair value? The narrative leans heavily on steady revenue expansion, firmer margins, and a rich future earnings multiple. The exact mix of those assumptions is where the story gets interesting.

Result: Fair Value of $20.17 (UNDERVALUED)

However, this story could be knocked off course if biotech tenant credit issues deepen or if higher refinancing costs squeeze earnings and limit balance sheet flexibility.

Next Steps

Mixed signals so far, right? With both risks and potential rewards in the picture, act promptly and review the full 3 key rewards and 4 important warning signs

Looking for more investment ideas?

If Healthpeak has your attention, do not stop here. Use this momentum to broaden your watchlist and give yourself more high quality options.

• Spot income opportunities by checking out companies that appear in the 13 dividend fortresses so you are not relying on a single payer for yield.
• Hunt for potential value by scanning the screener containing 23 high quality undiscovered gems and see which names the market may not be focusing on yet.
• Prioritize resilience by reviewing the 74 resilient stocks with low risk scores and line up candidates that might better match your risk tolerance.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.